ATE427749T1 - Inhibitoren einer augendruck-erhíhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten - Google Patents

Inhibitoren einer augendruck-erhíhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten

Info

Publication number: ATE427749T1
Authority: AT; Austria
Prior art keywords: inhibitors; increase; alkyl; laser radiation; pressure caused
Prior art date: 1999-01-29

Application number

AT00901928T

Other languages

English (en)

Inventor

Mitsunori Waki

Original Assignee

Senju Pharma Co

Kyoto Pharma Ind

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-29

Filing date

2000-01-27

Publication date

2009-04-15

2000-01-27 Application filed by Senju Pharma Co, Kyoto Pharma Ind filed Critical Senju Pharma Co

2009-04-15 Application granted granted Critical

2009-04-15 Publication of ATE427749T1 publication Critical patent/ATE427749T1/de

Links

YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 2
239000003112 inhibitor Substances 0.000 title 1
230000005855 radiation Effects 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
206010061218 Inflammation Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000005354 acylalkyl group Chemical group 0.000 abstract 1
125000005041 acyloxyalkyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000005242 carbamoyl alkyl group Chemical group 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000004966 cyanoalkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 abstract 1
125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 abstract 1
125000001188 haloalkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
-1 nitratoalkyl Chemical group 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)

AT00901928T 1999-01-29 2000-01-27 Inhibitoren einer augendruck-erhíhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten ATE427749T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2224999		1999-01-29

Publications (1)

Publication Number	Publication Date
ATE427749T1 true ATE427749T1 (de)	2009-04-15

Family

ID=12077527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00901928T ATE427749T1 (de)	1999-01-29	2000-01-27	Inhibitoren einer augendruck-erhíhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten

Country Status (7)

Country	Link
US (1)	US6630473B1 (de)
EP (2)	EP1915996A1 (de)
AT (1)	ATE427749T1 (de)
CA (1)	CA2360689A1 (de)
DE (1)	DE60041963D1 (de)
ES (1)	ES2322538T3 (de)
WO (1)	WO2000044383A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005289814A (ja) *	2002-04-12	2005-10-20	Mei Co Ltd	近視矯正手術のための医薬
US7652153B2 (en)	2004-02-27	2010-01-26	Vertex Pharmaceuticals Incorporated	Caspase inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0688973B2 (ja)	1987-03-12	1994-11-09	京都薬品工業株式会社	１，４−ジヒドロピリジン誘導体
JPH03145464A (ja)	1989-10-30	1991-06-20	Kyoto Yakuhin Kogyo Kk	光学活性１，４―ジヒドロピリジン誘導体
JPH04244081A (ja)	1991-01-31	1992-09-01	Kaken Pharmaceut Co Ltd	１，４−ジヒドロピリジン誘導体およびそれを有効成分とするアレルギー性または炎症性疾患治療剤
JP3145464B2 (ja)	1991-09-30	2001-03-12	株式会社リコー	デカール装置
US5435998A (en)	1994-08-03	1995-07-25	Abelson; Mark B.	Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
JP4828670B2 (ja)	1996-10-28	2011-11-30	千寿製薬株式会社	眼循環障害改善剤

2000
- 2000-01-27 US US09/890,354 patent/US6630473B1/en not_active Expired - Fee Related
- 2000-01-27 EP EP08001756A patent/EP1915996A1/de not_active Withdrawn
- 2000-01-27 ES ES00901928T patent/ES2322538T3/es not_active Expired - Lifetime
- 2000-01-27 EP EP00901928A patent/EP1179345B1/de not_active Expired - Lifetime
- 2000-01-27 WO PCT/JP2000/000410 patent/WO2000044383A1/ja not_active Ceased
- 2000-01-27 DE DE60041963T patent/DE60041963D1/de not_active Expired - Lifetime
- 2000-01-27 AT AT00901928T patent/ATE427749T1/de not_active IP Right Cessation
- 2000-01-27 CA CA002360689A patent/CA2360689A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1915996A1 (de)	2008-04-30
ES2322538T3 (es)	2009-06-23
DE60041963D1 (de)	2009-05-20
CA2360689A1 (en)	2000-08-03
EP1179345A1 (de)	2002-02-13
US6630473B1 (en)	2003-10-07
WO2000044383A1 (en)	2000-08-03
EP1179345B1 (de)	2009-04-08
EP1179345A4 (de)	2006-08-09

Legal Events

Date	Code	Title	Description
2009-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DK1020439T3 (da)	2006-11-27	Inhibitorer af CETP-aktivitet
CY1112899T1 (el)	2016-04-13	Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
DK1063228T5 (da)	2009-06-15	Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
BR9405139A (pt)	1999-08-31	Derivados do triazol, inseticida e acaricida e processos para produção dos mesmos
KR940005534A (ko)	1994-03-21	아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
EP1634874A4 (de)	2008-04-02	Imidazolidinderivate
KR970706275A (ko)	1997-11-03	피리미디닐피라졸 유도체(Pyrimidinylpyrazole derivative)
KR950703941A (ko)	1995-11-17	일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor)
DE3851856D1 (de)	1994-11-24	1,4-Dihydropyridin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE427749T1 (de)	2009-04-15	Inhibitoren einer augendruck-erhíhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten
ATE320417T1 (de)	2006-04-15	Naphthimidobenzamid-derivate
PT99502A (pt)	1992-09-30	Processo para a preparacao de novos derivados de imidazol
ATE278405T1 (de)	2004-10-15	1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird.
PH23966A (en)	1990-01-23	Imidazoquinozoline compounds as agent for treatment of nephritis
ATE231155T1 (de)	2003-02-15	Azolderivative oder deren salze
KR950704243A (ko)	1995-11-17	아세트아미드 유도체(acetamide derivative)
TH14567A (de)	1994-08-26